Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00355719Phase 4Completed
Phase 4, open-label, single-arm trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Atazanavir plasma concentration at Week 4. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00355719.